Drug recall: Glenmark Recalls 114 Batches Of Hypokalemia Drug

The drug recall is due to "failed dissolution," which means the capsules may not release the potassium chloride medication properly.

234

Last Updated on July 9, 2024 by The Health Master

Drug recall

If you take medication for low potassium levels (hypokalemia), be aware of a recent drug recall by Glenmark Pharmaceuticals Inc., USA.

They are voluntarily recalling 114 batches of their Potassium Chloride Extended-Release Capsules (750mg) due to a serious quality control issue.

Risk of High Potassium Levels (Hyperkalemia)

The drug recall is due to “failed dissolution,” which means the capsules may not release the potassium chloride medication properly.

This could lead to dangerously high potassium levels in your blood, also known as hyperkalemia.

Potential Complications of Hyperkalemia

Hyperkalemia is a serious medical condition that can cause a range of health problems, including:

  • Irregular heartbeat (arrhythmias)
  • Muscle weakness, which can be severe
  • Cardiac arrest (sudden death)

Who is Most at Risk?

The risk of hyperkalemia is especially high for patients who:

  • Take Potassium Chloride Extended-Release capsules chronically
  • Have underlying health conditions like high blood pressure (hypertension), heart failure, or kidney problems (renal dysfunction)

What to Do if You’ve Taken the Recalled Medication

  • Stop taking the medication immediately.
  • Consult your doctor to discuss alternative treatment options and to monitor your potassium levels.
  • Check the lot number of your Potassium Chloride Extended-Release Capsules. A list of recalled batches can be found on the FDA website.

Important Note:

  • Glenmark Pharmaceuticals has not received any reports of hyperkalemia or serious adverse events related to this recall yet. However, it’s crucial to be aware of the potential risks and take action to protect your health.

Additional Information

  • The recalled capsules are packaged in bottles of 100 (NDC 68462-357-01) and 500 (NDC 68462-357-05) capsules.
  • The capsules were distributed nationwide to wholesalers, distributors, and retail outlets across the United States.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news